CE Event Recap: New Treatments for Geographic Atrophy and Diabetic Macular Edema
On October 3, 2024, Retina Consultants of Texas hosted a dynamic CE event led by Dr. Effie Rahman, featuring presentations from Dr. Jeremiah Brown and Dr. Patrick Staropoli. The evening centered on advancements in the treatment of geographic atrophy (GA) and diabetic macular edema (DME), two major causes of vision loss in patients with retinal conditions.
Geographic Atrophy: A New Frontier
Dr. Jeremiah Brown opened the session with an exploration of GA, an advanced form of dry age-related macular degeneration. With 1.5 million Americans affected, and GA contributing to 20% of AMD-related blindness, this condition demands early detection and innovative management. Highlights from the presentation included:
- Early Detection: The critical role of OCT and multimodal imaging in identifying GA.
- Understanding GA: Multifactorial causes, including genetics, oxidative stress, and environmental factors.
- New Treatments: Emerging therapies that offer hope for slowing GA progression.
Dr. Brown emphasized the importance of patient education, particularly in helping patients understand their diagnosis and treatment options.
Diabetic Macular Edema: Trends, Classification, and Treatments
Dr. Staropoli shifted the focus to DME, a condition affecting 13.6% of patients with (link: treatment/retina-conditions/diabetic-retinopathy text: diabetic retinopathy. With DR on the rise globally, early identification and effective treatment are paramount. Key takeaways from the presentation included:
- Comorbidities: The link between diabetes and DME.
- Severity Scales: How the diabetic retinopathy severity scale (DRSS) aids in research and treatment planning.
- Treatment Options: A review of lasers, injections, and surgical interventions, with insights into the latest research findings.
To attend Retina Consultants of Texas’s next CE Zoom event, please register here for updates.
